– Global kidney cancer diagnostics market to top US$ 1.2 Bn by 2031. – Immunochemistry tests projected to reach around US$ 550 Mn by 2031. – Urine tests projected to record above 5% CAGR over next 10 years. – Market in North America holds share of more than 50%. – Market in South Korea expected to reach valuation of US$ 350 Mn by 2031. – Market in Australia to record 4% CAGR over forecast period of 2021- 2031.